Incyte | 资产

股票价格
99.98
每天变化
-1.07 -1.06%
每月一次
-2.53%
每年
34.56%
Q1 预测
98.18


金融业
股票价格
USD
资产
USD 6.96B
现金及等价物
USD 3.58B
销售成本
USD 121.18M
流动资产
USD 5.02B
流动负债
USD 1.52B
债务
USD 40.41M
EBIT
USD 383.88M
EBITDA
USD 414.51M
员工
2.62K
EPS每股收益
USD 1.8
股本和储备
USD 5.17B
销售毛利
USD 1.39B
债务利息支出
USD 582K
利息收入
USD 30.75M
贷款资金
USD 30.2M
市值
USD 22.69B
净收入
USD 299.28M
营业费用
USD 1.12B
营业利润
USD 383.88M
普通股股本
USD 198.46M
PE价格收益
USD 14.84
税前利润
USD 389.94M
销售收入
USD 1.51B
销售和管理费用
USD 390.41M
股票
USD 101.06M
贸易债权人
USD 1.63B
应收帐款人
USD 1.02B


资产 更改 日
Acadia Pharmaceuticals USD 1.33B 105.22M 2025-09
Agenus USD 233.89M 48.67M 2025-09
Agios Pharmaceuticals USD 1.3B 88.48M 2025-12
Alnylam Pharmaceuticals USD 4.97B 114.67M 2025-12
Amgen USD 90.59B 445M 2025-12
BioCryst Pharmaceuticals USD 446.42M 10.76M 2025-09
Biogen USD 29.44B 232M 2025-12
BioMarin Pharmaceutical USD 7.59B 20.85M 2025-12
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Eli Lilly USD 112.48B 2.46B 2025-12
Exelixis USD 2.84B 20.87M 2025-12
Gilead Sciences USD 59.02B 490M 2025-12
Incyte USD 6.96B 627.62M 2025-12
Ionis Pharmaceuticals USD 3.03B 47.96M 2025-09
MacroGenics USD 270.76M 25.34M 2025-09
Merck USD 129.55B 12.02B 2025-09
Moderna USD 12.34B 203M 2025-12
Nektar Therapeutics USD 301.35M 93.81M 2025-09
Neurocrine Biosciences USD 4.63B 365.8M 2025-12
Novartis USD 107.29B 2.89B 2025-09
Novartis USD 107.29B 2.89B 2025-09
Pfizer USD 208.73B 2.64B 2025-09
PTC Therapeutics USD 2.9B 255.07M 2025-12
Puma Biotechnology USD 202.86M 7.95M 2025-09
Regeneron Pharmaceuticals USD 40.56B 389.3M 2025-12
Sarepta Therapeutics USD 3.49B 186.38M 2025-09
Ultragenyx Pharmaceutical USD 1.53B 341.56M 2025-12
Vertex Pharmaceuticals USD 25.64B 780.7M 2025-12


Incyte 资产 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.